Concepedia

Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy

Josimar O. Eloy, Raquel Petrilli, Deise L. Chesca, Fabiano Pinto Saggioro, Robert J. Lee, Juliana Maldonado Marchetti

European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 116 citations · 26 references

Open access

Concepts

MedicineOncologyPharmacologyDrug DeliveryMolecular OncologyNanoparticle Drug DeliveryBreast Cancer PharmacotherapyCancer Drug DeliveryCancer ImmunotherapyHer2-positive Breast CancerImmunotherapy For Breast CancerMetastatic Breast CancerBreast Cancer ChemotherapyHer2 InhibitorsHer2-positive Breast Cancer ImmunotherapyHer2-positive Breast Cancer TherapyHuman Epidermal Growth Factor Receptor 2-Targeted Therapy

References

26

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Ting‐Chao Chou, Paul Talalay · Advances in Enzyme Regulation · 1984 · 7.2K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Targeted drug delivery to tumors: Myths, reality and possibility

You Han Bae, Kinam Park · Journal of Controlled Release · 2011 · 1.9K citations · Full text

Pharmacy, Oncology, Pharmacology +12

Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation

Yang Tao, Cui Fu-de, Min-Koo Choi et al. · International Journal of Pharmaceutics · 2007 · 387 citations

Pharmacy, Pharmaceutics, Pharmacology +16

Tumor targeting using anti-her2 immunoliposomes

J.W. Park, Dmitri B. Kirpotin, Keelung Hong et al. · Journal of Controlled Release · 2001 · 332 citations

Medicine, Cancer Biology, Oncology +12

Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells

Wallace H. Mondesire, Weiguo Jian, Haixia Zhang et al. · Clinical Cancer Research · 2004 · 318 citations

Medicine, Oncology, Pharmacology +17